mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.07 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.08 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.098 |
0.08 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |